March 11, 2013 The Trial Of Five Plaintiffs VS. LLNS (Lawrence Livermore Lab) To Start In The Alameda Co. Superior Court: Department 20 - Case RG09453596 - WECT TV6-WECT.com:News, weather & sports Wilmington, NC

March 11, 2013 The Trial Of Five Plaintiffs VS. LLNS (Lawrence Livermore Lab) To Start In The Alameda Co. Superior Court: Department 20 - Case RG09453596

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE The Law Firm of Gwilliam, Ivary, Chiosso, Cavalli & Brewer

 

OAKLAND, Calif., March 7, 2013 /PRNewswire/ -- Gwilliam, Ivary, Chiosso, Cavalli & Brewer releases: Following almost four years of intense litigation five of the 130 plaintiffs in the case of Andrews vs. LLNS look forward to the opportunity to have their case heard at trial beginning March 11, 2013 in Alameda Superior Court, Department 20.  

In 2008, 430 permanent employees were laid off by the lab shortly after the lab's privatization led by Bechtel Corporation, the multinational engineering company based in San Francisco.  In May of 2009 130 of the 430 employees, represented by law firm of Gwilliam, Ivary, Chiosso, Cavalli & Brewer, filed suit against LLNS for wrongful termination, breach of contract, and individual allegations ranging from age discrimination to retaliation.  

The first five plaintiffs (Elaine Andrews, Marian Barraza, Mario Jimenez, Greg Olsen and James Torrice) of the 130 will proceed to trial on March 11, 2013.  This is being called Phase One. These five plaintiffs allege breach of contract and breach of the implied covenant of good faith and fair dealing and one plaintiff has a claim for retaliation.

CONTACT:   For further comment please feel free to contact Attorney J. Gary Gwilliam or Attorney Randall E. Strauss of the law firm of Gwilliam, Ivary, Chiosso, Cavalli & Brewer at 510-832-5411.

 

 

©2012 PR Newswire. All Rights Reserved.